Vivo Bio Tech

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE380K01017
  • NSEID: VIVOBIOT
  • BSEID: 511509
INR
15.77
1.15 (7.87%)
BSENSE

Nov 20

BSE+NSE Vol: 20.44 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Guj. Terce Labs.
Roopa Industries
Sandu Pharma.
Vivo Bio Tech
Medi Caps
Vista Pharma.
Bharat Immunolog
Murae Organisor
Goldline Pharmac
Bacil Pharma
Medicamen Organ.
Why is Vivo Bio Tech Ltd ?
1
Weak Long Term Fundamental Strength with a 2.97% CAGR growth in Net Sales over the last 5 years
  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 1.55
  • The company has been able to generate a Return on Equity (avg) of 4.83% signifying low profitability per unit of shareholders funds
2
Flat results in Sep 26
  • ROCE(HY) Lowest at 5.74%
  • DEBTORS TURNOVER RATIO(HY) Lowest at 3.27 times
  • INTEREST(Q) Highest at Rs 2.02 cr
3
Stock is technically in a Mildly Bearish range
  • Multiple factors for the stock are Bearish like MACD, Bollinger Band and KST
4
Reducing Promoter Confidence
  • Promoters have decreased their stake in the company by -8.11% over the previous quarter and currently hold 22.51% of the company
  • Promoters decreasing their stake may signify reduced confidence in the future of the business
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Vivo Bio Tech for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Vivo Bio Tech
-49.94%
-0.90
55.47%
Sensex
-2.0%
-0.13
14.98%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
2.97%
EBIT Growth (5y)
-4.77%
EBIT to Interest (avg)
1.55
Debt to EBITDA (avg)
3.15
Net Debt to Equity (avg)
0.86
Sales to Capital Employed (avg)
0.39
Tax Ratio
100.00%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
8.52%
ROE (avg)
4.83%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
40
Price to Book Value
0.39
EV to EBIT
13.83
EV to EBITDA
5.50
EV to Capital Employed
0.67
EV to Sales
1.96
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
4.86%
ROE (Latest)
-2.82%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

11What is working for the Company
PAT(Latest six months)

Higher at Rs 1.29 cr

NET SALES(Q)

Highest at Rs 17.19 cr

PBDIT(Q)

Highest at Rs 6.08 cr.

-10What is not working for the Company
ROCE(HY)

Lowest at 5.74%

DEBTORS TURNOVER RATIO(HY)

Lowest at 3.27 times

INTEREST(Q)

Highest at Rs 2.02 cr

NON-OPERATING INCOME(Q)

is 82.89 % of Profit Before Tax (PBT

Loading Valuation Snapshot...
Here's what is working for Vivo Bio Tech
Net Sales - Quarterly
Highest at Rs 17.19 cr and Grown
each quarter in the last five quarters
MOJO Watch
Near term sales trend is very positive

Net Sales (Rs Cr)

Profit After Tax (PAT) - Latest six months
Higher at Rs 1.29 cr
than preceding 12 month period ended Sep 2026 of Rs -1.70 cr
MOJO Watch
In the half year the company has already crossed PAT of the previous twelve months

PAT (Rs Cr)

Net Sales - Quarterly
At Rs 17.19 cr has Grown at 24.8% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 13.78 Cr
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Highest at Rs 6.08 cr.
in the last five quarters
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (Rs Cr)

Here's what is not working for Vivo Bio Tech
Interest - Quarterly
At Rs 2.02 cr has Grown at 62.90%
Quarter on Quarter (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (Rs cr)

Interest - Quarterly
Highest at Rs 2.02 cr
in the last five quarters and Increased by 62.90 % (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (Rs cr)

Non Operating Income - Quarterly
is 82.89 % of Profit Before Tax (PBT)
MOJO Watch
The company's income from non business activities is high; which is not a sustainable business model

Non Operating Income to PBT

Debtors Turnover Ratio- Half Yearly
Lowest at 3.27 times
in the last five half yearly periods
MOJO Watch
Company's pace of settling its Debtors has slowed

Debtors Turnover Ratio

Non Operating Income - Quarterly
Highest at Rs 1.55 cr
in the last five quarters
MOJO Watch
Increased income from non business activities may not be sustainable

Non Operating Income